Volume 5 Supplement 1

Proceedings of the 12-th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI)

Open Access

Bim nuclear translocation and inactivation by HHV-8 interferon regulatory factor 1

Infectious Agents and Cancer20105(Suppl 1):A7

https://doi.org/10.1186/1750-9378-5-S1-A7

Published: 11 October 2010

Viral replication efficiency is in large part governed by the ability of viruses to counteract pro-apoptotic signals induced by infection of host cells. In HHV-8, one group of proteins acting to suppress the host’s innate defenses is the set of four viral interferon regulatory factors (vIRFs 1-4), which act to block cellular IRF activities in addition to targeting and inhibiting p53 and other inducers of apoptosis. We observed that in a large proportion of endothelial cells supporting lytic reactivation, the normally cytoplasmic pro-apoptotic BH3-only protein Bim, a negative regulator of HHV-8 productive replication, was localized in the nucleus. Nuclear localization of Bim could be induced in cells cotransfected with vIRF-1, and confocal microscopy identified co-localization of vIRF-1 and Bim in the nuclei of lytically reactivated cells. Physical association of vIRF-1 and Bim was identified in co-precipitation experiments using both transfected cell lysates and purified recombinant vIRF-1 and Bim. In vitro binding studies using a series of truncation and point variants of vIRF-1 enabled precise mapping of the Bim-interacting residues (Bim-binding domain, BBD) of vIRF-1. Wild-type, but not mutated, BBD fused to a nuclear localization signal was sufficient to induce Bim nuclear translocation in transfected cells; BBD-mutated vIRF-1 proteins were unable to do so or to protect cells from Bim-induced apoptosis. Depletion of endogenous vIRF-1 led to reductions in virus production and increased apoptosis in lytically reactivated endothelial cultures, while transduced expression of wild-type vIRF-1 promoted virus production and inhibited apoptosis. Experimental utilization of Bim-refractory vIRF-1 variants revealed the importance of vIRF-1:Bim interaction, specifically, for pro-replication and anti-apoptotic activity of vIRF-1. Furthermore, blocking of the interaction with cell-permeable peptide corresponding to the Bim-binding region of vIRF-1 confirmed the relevance of vIRF-1:Bim association to vIRF-1 pro-replication activity. To our knowledge, this is the first report of an IRF protein that interacts with a Bcl-2 family member and of nuclear sequestration of Bim or any other member of the family as a means of inactivation. Our data reveal a novel mechanism utilized by a virus to control replication-induced apoptosis and suggest that inhibitory targeting of vIRF-1:Bim interaction may provide an effective antiviral strategy.

Declarations

Acknowledgements

This article has been published as part of Infectious Agents and Cancer Volume 5 Supplement 1, 2010: Proceedings of the 12th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI).The full contents of the supplement are available online at http://www.biomedcentral.com/1750-9378/5?issue=S1.

Authors’ Affiliations

(1)
Department of Oncology, Johns Hopkins University School of Medicine

Copyright

© Nicholas and Choi; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd.

Advertisement